7. Corticobasal degeneration Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 28 - (DrugBank : 13) / Drug target genes : 9 - Drug target pathways : 38
Corticobasal degeneration and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
7 | Corticobasal degeneration |
2 | Amyotrophic lateral sclerosis |
17 | Multiple system atrophy |
5 | Progressive supranuclear palsy |
6 | Parkinson disease |
74 | Prolactin secreting pituitary adenoma |
4 | Primary lateral sclerosis |
201 | Angelman syndrome |
164 | Oculocutaneous albinism |
140 | Dorabe syndrome |
90 | Retinitis pigmentosa |
299 | Cystic fibrosis |
309 | Progressive myoclonus epilepsy |
51 | Scleroderma |
20 | Adrenoleukodystrophy |
8 | Huntington disease |
86 | Pulmonary arterial hypertension |